document.getElementById('index-articles-list').innerHTML = `
  • Relapse Risk in Patients with Membranous Nephropathy after Inactivated COVID-19 Vaccination
    COVID-19疫苗接种后膜性肾病患者的复发风险

    Hanzhen Zhang,Ruiying Chen,Mingyue Xu et al.

    Nephron. 2025 Apr 2:1-11. DOI:10.1159/000544754

  • Can-SOLVE CKD: reflections on successes, challenges, and future opportunities in patient-oriented kidney research
    加拿大CAN-_solve CKD:以患者为导向的肾脏病研究的成功、挑战与未来机遇反思

    Melanie D Talson,Michelle Hampson,Kelly Loverock et al.

    Nephron. 2025 Apr 1:1-11. DOI:10.1159/000544968

  • Further Clinical and Biochemical Phenotype of GLA p.A143T: a Fabry Disease Newborn Screening Experience
    进一步临床和生化表型的GLA p.A143T: 果糖病新生儿筛查体验

    Allison M Paltzer,Allegra M Quadri,Carly Rasmussen et al.

    Nephron. 2025 Mar 28:1-14. DOI:10.1159/000543920

  • Dapagliflozin Treatment Attenuates the Interaction Between the Renal Sodium Chloride co-transporter and Ezrin in Hypertensive Diabetic db/db Mice
    dapagliflozin治疗减轻了糖尿病db/db小鼠中高血压状态下肾钠氯协同转运蛋白和ezrin的相互作用

    Mohammed F Gholam,Abdel A Alli

    Nephron. 2025 Mar 21:1-30. DOI:10.1159/000543336

  • Second Opinion SGLT2 Inhibitors and Uric acid
    第二种意见 SGLT2抑制剂和尿酸

    Laura G Sanchez-Lozada,Miguel A Lanaspa,Bernardo Rodriguez-Iturbe et al.

    Nephron. 2025 Mar 21:1-8. DOI:10.1159/000545131

  • `; document.getElementById('index-articles-more').href = `https://i.iikx.com/journal/2235-3186.html`; document.getElementById('index-articles-more').innerHTML='更多内容'; document.getElementById('index-articles-more').style="float:right;background:var(--primary-color);color:#fff;font-size:13px;border-radius:5px;padding:0px 10px;margin-right:5px;line-height:1.7"; document.getElementsByClassName('index-artcles')[0].style.display = 'block'; document.getElementById('showJournalIndexUrl').style.display = 'block'; document.querySelector('#showJournalIndexUrl a').href = `https://i.iikx.com/journal/2235-3186.html`;